Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cell death : An anti-rejection drug for the treatment of Huntington’s disease

07.02.2006


At the Institut Curie, CNRS and Inserm researchers have shown that Huntington’s disease may be treated using the drug FK506, which is also used clinically to prevent graft rejection. Like Alzheimer’s and Parkinson’s, Huntington’s disease is characterized by the abnormal death of neurons.



The Institut Curie researchers have discovered that FK506 blocks the toxicity of the protein huntingtin, which causes the death of certain neurons leading to disease onset. FK506 is already used in a clinical setting and so is a candidate for fast-track development as a treatment for Huntington’s disease.

This study was published in the February 1, 2006 issue of The Journal of Neuroscience.


Huntington’s disease is a genetic disorder which affects approximately 6 000 people in France and is of concern to over 12 000 carriers of the mutated gene as yet untouched by clinical signs. It is characterized by uncontrolled movements, personality changes, dementia and death 10 to 20 years after onset of the first symptoms (see "Additional information").

Huntington’s disease results from changes in the IT15 gene, which encodes a protein, huntingtin, whose function is incompletely elucidated. Normal huntingtin contains repeats of the amino acid glutamine, but mutant huntingtin contains more than 35 to 40 glutamines and induces the disease. Symptoms occur earlier as the number of repeats increases.

This abnormal expansion of the polyglutamine tract in huntingtin results in structural changes, and the mutant huntingtin accumulates in neurons thereby causing their dysfunction and ultimately their death.

The same type of mutation causes other neurodegenerative diseases, each involving different regions of the brain. In Huntington’s disease, degeneration occurs in the neurons of the striatum, which are involved in the control of movement.

Raúl Pardo and Emilie Colin at the Institut Curie are studying the mechanisms that lead to neuron death in Huntington’s disease, under the direction of Frédéric Saudou and Sandrine Humbert(1).

They have now shown that calcineurin, a protein abundant in the brain, chemically alters mutant huntingtin, which becomes more toxic for neurons.

They have also discovered that by inhibiting calcineurin, FK506 “corrects” this chemical alteration in mutant huntingtin both in cultured neurons and in an animal model of the disease. FK506 even prevents the death of the striatal neurons. So, FK506 negates the harmful effects of mutant huntingtin in neurons.

FK506 is already used therapeutically to prevent graft rejection, and so may be a candidate for fast-track development as a treatment for Huntington’s disease.

Catherine Goupillon | alfa
Further information:
http://www.jneurosci.org/
http://www.curie.fr

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>